A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults

NCT05252338 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: CVSQIV

Sponsor

CureVac

Collaborators

[object Object]